IVBT (Innovation1 Biotech) Interest Expense: $-0.45 Mil (TTM As of Feb. 2024)


IVBT Innovation1 Biotech Inc IVBT
12 GF Score
Price $0.00
View Full Analysis

What is Innovation1 Biotech Interest Expense?

Innovation1 Biotech IVBT 12 Interest Expense is $-0.45 Mil as of Feb. 2024. GuruFocus rates IVBT with a GF Score™ of 12/100.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Innovation1 Biotech's interest expense for the three months ended in Feb. 2024 was $ -0.14 Mil. Its interest expense for the trailing twelve months (TTM) ended in Feb. 2024 was $-0.45 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Innovation1 Biotech's Operating Income for the three months ended in Feb. 2024 was $ -0.15 Mil. Innovation1 Biotech's Interest Expense for the three months ended in Feb. 2024 was $ -0.14 Mil. Innovation1 Biotech did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Innovation1 Biotech  (OTCPK:IVBT) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Innovation1 Biotech's Interest Expense for the three months ended in Feb. 2024 was $-0.14 Mil. Its Operating Income for the three months ended in Feb. 2024 was $-0.15 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Feb. 2024 was $0.56 Mil.

Innovation1 Biotech's Interest Coverage for the quarter that ended in Feb. 2024 is calculated as

Innovation1 Biotech did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Innovation1 Biotech Interest Expense Historical Data

* Premium members only.

The historical data trend for Innovation1 Biotech's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation1 Biotech Interest Expense Chart

Innovation1 Biotech Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Interest Expense
Get a 7-Day Free Trial Premium Member Only -0.00 -1.30 -0.22 -0.01 -0.25

Innovation1 Biotech Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.10 -0.12 -0.10 -0.14
IVBT
12GF Score
Innovation1 Biotech Inc IVBT
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innovation1 Biotech Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.45 Mil mean?
Innovation1 Biotech (IVBT) has a Interest Expense of $-0.45 Mil as of Feb. 2024. Interest Expense is the amount a company pays on its long-term debt. View historical data on Innovation1 Biotech and its competitors.
Is Innovation1 Biotech's Interest Expense too high?
Innovation1 Biotech's current Interest Expense is $-0.45 Mil. Overall, Innovation1 Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Innovation1 Biotech's Interest Expense compare to NVIV and PXMD?
Innovation1 Biotech's Interest Expense of $-0.45 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Diversified Financial Services company?
A good Interest Expense depends on the Diversified Financial Services industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Innovation1 Biotech and its competitors. Innovation1 Biotech's current Interest Expense is $-0.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovation1 Biotech stock overvalued right now?
Innovation1 Biotech (IVBT) has a current Interest Expense of $-0.45 Mil. The current Interest Expense is $-0.45 Mil. Innovation1 Biotech's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Innovation1 Biotech (IVBT), the current Interest Expense is $-0.45 Mil as of Feb. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation1 Biotech Business Description

Address 7 Grand View Avenue, Somerville, MA, USA, 02143
Innovation1 Biotech Inc is a shell company.
12GF Score

Get the complete analysis for IVBT

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price